CDH1 and endometrial cancer: Indeed, reduced E-cadherin expression is associated with advanced stage [30, 40], poor differentiation [30, 41], deep myometrial invasion [29, 40, 41], lymph node metastasis [26], and extra-pelvic recurrence [42] in endometrial cancer.